| Announce Date | 12/04/2025 |
| EPS Normalized Actual | $0.32 (Beat by $0.0183) |
| EPS GAAP Actual | $0.32 (Beat by $0.0183) |
| Revenue Actual | $3.18566B |
| Revenue Surprise | Beat by $3185.66M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Oct 2028 | 1.75 | 13.59 | 1.71888 | 1.77039 | 1 |
| Oct 2028 | 1.67667 | 14.18 | 1.63242 | 1.72092 | 2 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Oct 2025) | -0.1 | -0.1 | 3.18566B | 1.49% | 3185.66M |
| FQ3 2025 (Jul 2025) | 0.33 | 0.33 | 3.03288B | 4.43% | 3032.88M |
| FQ2 2025 (Apr 2025) | 0.33 | 0.33 | 2.89881B | 0.4% | 2898.81M |
| FQ1 2025 (Jan 2025) | 0.31 | 0.31 | 2.98881B | -0.27% | 2988.81M |
| FQ4 2024 (Oct 2024) | 0 | 0 | 3.13809B | -1.91% | 3138.09M |
| FQ3 2024 (Jul 2024) | 0.32 | 0.32 | 2.89844B | -2.24% | 2898.44M |
| FQ2 2024 (Apr 2024) | 0.35 | 0.35 | 2.88735B | -3.13% | 2887.35M |
| FQ1 2024 (Jan 2024) | 0.4 | 0.4 | 2.99691B | 0.86% | 2996.91M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Oct 2027) | 0.61 | -- | 0.60862 | 0.61219 | 2 |
| FQ3 2027 (Jul 2027) | 0.54 | -- | 0.53878 | 0.54193 | 2 |
| FQ2 2027 (Apr 2027) | 0.46 | -- | 0.45896 | 0.46165 | 2 |
| FQ1 2027 (Jan 2027) | 0.47 | -- | 0.46894 | 0.47168 | 2 |
| FQ4 2026 (Oct 2026) | 0.53 | 118.87 | 0.52048 | 0.54449 | 2 |
| FQ3 2026 (Jul 2026) | 0.455 | 27.47 | 0.44683 | 0.46744 | 2 |
| FQ2 2026 (Apr 2026) | 0.46 | 28.26 | 0.45387 | 0.4673 | 4 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Oct 2027) | 3.42B | -- | 3.42B | 3.43B | 2 |
| FQ3 2027 (Jul 2027) | 3.14B | -- | 3.13B | 3.14B | 2 |
| FQ2 2027 (Apr 2027) | 3.06B | -- | 3.05B | 3.07B | 2 |
| FQ1 2027 (Jan 2027) | 3.18B | -- | 3.18B | 3.19B | 2 |
| FQ4 2026 (Oct 2026) | 3.2B | 0.41 | 3.15B | 3.27B | 3 |
| FQ3 2026 (Jul 2026) | 2.98B | -1.64 | 2.94B | 3.05B | 3 |
| FQ2 2026 (Apr 2026) | 3.04B | 4.5 | 3B | 3.07B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
1
EPS # of in-lines
1
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Oct 2025) | -0.1 | -0.1 | 100% | |
| FQ3 2025 (Jul 2025) | 0.33 | 0.33 | 100% | |
| FQ2 2025 (Apr 2025) | 0.33 | 0.33 | 100% | |
| FQ1 2025 (Jan 2025) | 0.31 | 0.31 | 100% | |
| FQ4 2024 (Oct 2024) | 0 | 0 | NAN% | |
| FQ3 2024 (Jul 2024) | 0.32 | 0.32 | 100% | |
| FQ2 2024 (Apr 2024) | 0.35 | 0.35 | 100% | |
| FQ1 2024 (Jan 2024) | 0.4 | 0.4 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Oct 2025) | $0B | $3.19B | $3185.66M | 100% |
| FQ3 2025 (Jul 2025) | $0B | $3.03B | $3032.88M | 100% |
| FQ2 2025 (Apr 2025) | $0B | $2.9B | $2898.81M | 100% |
| FQ1 2025 (Jan 2025) | $0B | $2.99B | $2988.81M | 100% |
| FQ4 2024 (Oct 2024) | $0B | $3.14B | $3138.09M | 100% |
| FQ3 2024 (Jul 2024) | $0B | $2.9B | $2898.44M | 100% |
| FQ2 2024 (Apr 2024) | $0B | $2.89B | $2887.35M | 100% |
| FQ1 2024 (Jan 2024) | $0B | $3B | $2996.91M | 100% |